Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting

NACompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

July 29, 2020

Study Completion Date

November 22, 2020

Conditions
Supraventricular Tachycardia
Interventions
DRUG

adenosine

patients received IV adenosine 6 mg bolus then wait 2 minutes, if it failed to return to sinus rhythm then another 12 mg IV bolus of adenosine was administered, if supraventricular tachycardia persisted then the patient was shifted to verapamil.

DRUG

verapamil

patients received IV verapamil 5mg bolus slowly over 2 minutes followed by a second IV bolus dose of 5 mg ,10 minutes after the initial dose in case of persistence of supraventricular tachycardia (SVT). If SVT persisted, the patient was shifted to adenosine

Trial Locations (1)

11566

Ain Shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04203368 - Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting | Biotech Hunter | Biotech Hunter